Immune Checkpoint Inhibitor-induced Myocarditis

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-10-15
Clinical Trial Update: FDG-PET as an Imaging Modality to Diagnose and Risk Stratify Subclinical, Imaging Negative Ici-Myocarditis
A Mayo Clinic-sponsored trial is evaluating FDG-PET imaging to diagnose and risk stratify subclinical immune checkpoint inhibitor-induced my…